Lacombe C, Mayeux P, Casadevall N
Service d'Hématologie, Hôpital Cochin, Paris.
Nephrologie. 1991;12(5):221-6.
Erythropoietin (Epo) is a glycoprotein that promotes the proliferation and differentiation of erythrocyte precursors. The major site of Epo production is the kidney and the liver is the main extra renal site of Epo production. Epo producing cells were identified by in situ hybridization, in the kidney, they are peritubular cells, most likely endothelial cells of the cortex and outer medulla; in the liver, they are mainly hepatocytes. The Epo secretion is stimulated by hypoxia, which is detected by an oxygen sensor. The Epo receptor is a multimeric protein, one chain which binds Epo has been cloned. However the structure of the Epo receptor is still puzzling, and one or more accessory chains remain to be identified. Since the clonage of the Epo gene, recombinant Epo has been available and allowed the treatment of patients with renal diseases with a constant efficacy.
促红细胞生成素(Epo)是一种糖蛋白,可促进红细胞前体的增殖和分化。Epo产生的主要部位是肾脏,肝脏是Epo产生的主要肾外部位。通过原位杂交鉴定了产生Epo的细胞,在肾脏中,它们是肾小管周围细胞,很可能是皮质和外髓质的内皮细胞;在肝脏中,它们主要是肝细胞。缺氧可刺激Epo分泌,缺氧由氧传感器检测。Epo受体是一种多聚体蛋白,已克隆出一条与Epo结合的链。然而,Epo受体的结构仍然令人困惑,一条或多条辅助链仍有待鉴定。自Epo基因克隆以来,重组Epo已可获得,并可一直有效地用于治疗肾病患者。